glycogentargeting
Glycogentargeting refers to strategies that utilize glycans, or carbohydrate structures, to direct therapeutic agents or imaging probes to specific cells or tissues. This approach leverages the unique and often abundant expression of certain glycans on the surface of particular cell types. These cell-surface glycans can act as recognition sites, akin to molecular addresses, that can be bound by specific ligands.
The principle behind glycogentargeting involves designing therapeutic or diagnostic molecules that are conjugated to a ligand
This targeting strategy is particularly promising in areas like cancer therapy, where abnormal glycosylation is a